Top Glass Vial Manufacturers Navigate Quality, Regulation, and Global Demand in a Rapidly Evolving Pharmaceutical Market

XINTAI, SHANDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global pharmaceutical packaging ...
Targeted Oncology

FDA Clears Larger Vial Size of Nelarabine Injection in T-ALL and T-LBL

The FDA has granted approval to a larger vial size of nelarabine injection (SH-111) for use in treatment of adult and ...

Shorla Oncology® Announces U.S. FDA Approval of Larger Vial Size for Nelarabine Intravenous Administration for the Treatment of T-cell Acute Lymphoblastic Leukemia and T-cell ...

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved the company’s oncology drug, Nelarabine Injection, ...
FiercePharma

FDA approves single-vial version of GSK's Menveo vaccine, ending need for reconstitution

GSK has won FDA approval for a single-vial formulation of its meningococcal disease vaccine Menveo, thereby ending the need for reconstitution that has existed since the product came to market in 2010 ...
Business Insider

Buzzy healthtech startup Vial slashed an entire division weeks before a $67 million raise from General Catalyst. Insiders say they had no idea the layoffs were coming.

Vial let go of its entire site network division, 40 to 50 people, last October, Insider has learned. These cuts followed an earlier round of layoffs during the summer. Just a month after the October ...